Author:
Marques Emiliana B.,Motta Nádia A.V.,Kummerle Arthur E.,Fraga Carlos A.M.,Barreiro Eliezer J.,Brito Fernanda C.F.,Scaramello Christianne B.V.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Fundação de Amparo à Pesquisa do Rio de Janeiro (FAPERJ)
Subject
Cardiology and Cardiovascular Medicine
Reference10 articles.
1. The new compound, LASSBio 294, increases the contractility of intact and saponin-skinned cardiac muscle from Wistar rats;Sudo;Br. J. Pharmacol.,2001
2. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues;Silva;Bioorg. Med. Chem.,2005
3. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition;Brito;Eur. J. Pharmacol.,2010
4. Anti-atherogenic effects of a new thienylacylhydrazone derivative, LASSBio-788, in rats fed a hypercholesterolemic diet;Motta;J. Pharmacol. Sci.,2013
5. Role of cholesterol in cardiovascular dysfunction;Saini;Can. J. Cardiol.,2004
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献